Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.23
-0.16 (-1.19%)
Apr 20, 2026, 4:08 PM HKT
Market Cap8.02B +62.6%
Revenue (ttm)1.16B +29.8%
Net Income303.29M +118.1%
EPS0.79 +115.2%
Shares Out382.19M
PE Ratio16.74
Forward PE12.94
Dividend0.41 (3.09%)
Ex-Dividend DateMay 28, 2026
Volume502,000
Average Volume934,018
Open13.20
Previous Close13.39
Day's Range13.06 - 13.32
52-Week Range8.59 - 20.82
Beta-0.04
RSI51.44
Earnings DateMar 30, 2026

About HKG:1858

Beijing Chunlizhengda Medical Instruments Co., Ltd. engages in the research and development, production, and trading of surgical implants, instruments, and related products in the People’s Republic of China. The company offers implantable orthopedic medical devices, joints, dentures, spine, sports medicine, trauma and orthopedic surgical instruments. It sells its products through distributors, or on ODM and OEM bases, as well as to hospitals directly. It also exports its products. Beijing Chunlizhengda Medical Instruments Co., Ltd. was incorpor... [Read more]

Sector Healthcare
Founded 1998
Employees 1,066
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1858
Full Company Profile

Financial Performance

In 2025, HKG:1858's revenue was 1.05 billion, an increase of 29.77% compared to the previous year's 805.86 million. Earnings were 272.54 million, an increase of 118.05%.

Financial numbers in CNY Financial Statements